The Automatic Implantable Cardioverter-Defibrillator (AICD) shows excellent survival rates for arrhythmia patients. Increased awareness and broader criteria could significantly expand AICD therapy
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Failed At:
2026-06-19T13:37:05.902483+00:00